Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05935982 · ClinicalTrials.gov registry record · Early Phase 1

Virtual Reality Exercise in a Community Highschool for Children With Disabilities

A Early Phase 1 study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Early Phase 1
Development phase
9
Enrollment target

NCT05935982: Completed Early Phase 1 study, sponsored by University of Alabama at Birmingham.

NCT05935982 is a Early Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05935982, a Early Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Early Phase 1
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to work with a community engagement group to develop and pilot a protocol for a virtual reality exergaming program for children with special needs at a high school.

Primary Outcome

The percentage of session attended over the 6 week duration. Values were found by taking the total number of session attended by each group, divided by the total number of session across 6 weeks.

Interventions

  • BEHAVIORAL Virtual reality exercise

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-09-18
Est. Completion 2024-08-26
Phase Early Phase 1
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05935982 record still lists

NCT05935982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Virtual reality exercise is the first listed.

NCT05935982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05935982 about?

NCT05935982 is a clinical study titled "Virtual Reality Exercise in a Community Highschool for Children With Disabilities". The purpose of this study is to work with a community engagement group to develop and pilot a protocol for a virtual reality exergaming program for children with special needs at a high school.

What is the current status of trial NCT05935982?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2023-09-18. Estimated completion is 2024-08-26.

What interventions are being tested in trial NCT05935982?

The interventions under investigation include: Virtual reality exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05935982?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05935982's enrollment target sits among peer trials

9 1745th of 2000 higher than 219 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05935982, the US trial registry maintained by the National Library of Medicine. NCT05935982 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.